documents: FDA-2005-N-0345-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-N-0345-0001 | FDA | FDA-2005-N-0345 | Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures; Proposed Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2006-02-02T05:00:00Z | 2006 | 2 | 2006-01-31T05:00:00Z | 2006-05-03T03:59:59Z | 2025-10-16T22:13:32Z | E6-1225 | 0 | 0 | 0900006480449864 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref